FR2385730A1 - Medicament a base d'extrait de physarum - Google Patents

Medicament a base d'extrait de physarum

Info

Publication number
FR2385730A1
FR2385730A1 FR7808962A FR7808962A FR2385730A1 FR 2385730 A1 FR2385730 A1 FR 2385730A1 FR 7808962 A FR7808962 A FR 7808962A FR 7808962 A FR7808962 A FR 7808962A FR 2385730 A1 FR2385730 A1 FR 2385730A1
Authority
FR
France
Prior art keywords
extract
physarum
medicinal product
based medicinal
enzymatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7808962A
Other languages
English (en)
Other versions
FR2385730B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of FR2385730A1 publication Critical patent/FR2385730A1/fr
Application granted granted Critical
Publication of FR2385730B1 publication Critical patent/FR2385730B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01108—Lactase (3.2.1.108)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01021—Beta-glucosidase (3.2.1.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01025—Beta-mannosidase (3.2.1.25), i.e. mannanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01039—Glucan endo-1,3-beta-D-glucosidase (3.2.1.39)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01052—Beta-N-acetylhexosaminidase (3.2.1.52)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01058—Glucan 1,3-beta-glucosidase (3.2.1.58)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01073—Licheninase (3.2.1.73)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01075—Glucan endo-1,6-beta-glucosidase (3.2.1.75)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01084—Glucan 1,3-alpha-glucosidase (3.2.1.84), i.e. mutanase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Extrait enzymatique de Physarum, sa préparation et ses utilisations thérapeutiques. L'extrait est obtenu par isolement d'enzymes cytolytiques de Physarum et lyophilisation de cet extrait avec formation d'une composition stérile et apyrogène. L'extrait enzymatique selon l'invention a des propriétés antimicrobiennes et en particulier antifongiques expoitables en thérapeutique.
FR7808962A 1977-03-28 1978-03-28 Medicament a base d'extrait de physarum Granted FR2385730A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB12919/77A GB1576891A (en) 1977-03-28 1977-03-28 Antimicrobial compositions containing extracts of light enzymes from physarum species

Publications (2)

Publication Number Publication Date
FR2385730A1 true FR2385730A1 (fr) 1978-10-27
FR2385730B1 FR2385730B1 (fr) 1981-07-10

Family

ID=10013545

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7808962A Granted FR2385730A1 (fr) 1977-03-28 1978-03-28 Medicament a base d'extrait de physarum

Country Status (20)

Country Link
JP (1) JPS542310A (fr)
AT (1) AT363589B (fr)
AU (1) AU519066B2 (fr)
BE (1) BE865369A (fr)
CA (1) CA1107646A (fr)
DE (1) DE2813282A1 (fr)
DK (1) DK134678A (fr)
ES (1) ES468236A1 (fr)
FI (1) FI780933A (fr)
FR (1) FR2385730A1 (fr)
GB (1) GB1576891A (fr)
GR (1) GR71706B (fr)
IE (1) IE46698B1 (fr)
IL (1) IL54364A0 (fr)
NL (1) NL7803291A (fr)
NO (1) NO781035L (fr)
NZ (1) NZ186783A (fr)
PT (1) PT67826B (fr)
SE (1) SE7803456L (fr)
ZA (1) ZA781758B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2520614A1 (fr) * 1982-02-03 1983-08-05 Rohto Pharma Procede et composition utilisant la b-1,3-glucanase pour le nettoyage des dentiers
WO1997047202A1 (fr) * 1996-06-07 1997-12-18 Gist-Brocades B.V. Compositions antifongiques

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4542020A (en) * 1984-08-17 1985-09-17 E. R. Squibb & Sons, Inc. Long-lasting adhesive antifungal suppositories
JPH0261164A (ja) * 1988-08-27 1990-03-01 Hisaka Works Ltd 処理槽への内槽装填・取り出し方法およびそれに用いる移載車。
JPH0261163A (ja) * 1988-08-27 1990-03-01 Hisaka Works Ltd 繊維材料取り出し方法およびそれに用いる装置

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CA1973 *
CA1975 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2520614A1 (fr) * 1982-02-03 1983-08-05 Rohto Pharma Procede et composition utilisant la b-1,3-glucanase pour le nettoyage des dentiers
WO1997047202A1 (fr) * 1996-06-07 1997-12-18 Gist-Brocades B.V. Compositions antifongiques

Also Published As

Publication number Publication date
FI780933A (fi) 1978-09-29
ATA215978A (de) 1981-01-15
NO781035L (no) 1978-09-29
FR2385730B1 (fr) 1981-07-10
NL7803291A (nl) 1978-10-02
JPS542310A (en) 1979-01-09
GR71706B (fr) 1983-06-21
NZ186783A (en) 1980-12-19
PT67826B (en) 1979-09-27
PT67826A (en) 1978-04-01
BE865369A (fr) 1978-09-28
AU3447978A (en) 1979-09-27
GB1576891A (en) 1980-10-15
ZA781758B (en) 1979-05-30
DK134678A (da) 1978-09-29
IE780623L (en) 1978-09-28
SE7803456L (sv) 1978-09-29
DE2813282A1 (de) 1978-10-12
AU519066B2 (en) 1981-11-05
AT363589B (de) 1981-08-10
ES468236A1 (es) 1978-12-01
IE46698B1 (en) 1983-08-24
CA1107646A (fr) 1981-08-25
IL54364A0 (en) 1978-06-15

Similar Documents

Publication Publication Date Title
FR2558373B1 (fr) Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
ES8403724A1 (es) Un procedimiento para preparar un complejo inmunogeno no covalentes de polisacarido-proteina, y obtenido a partir de capsulas bacterianas.
IL108865A (en) Azabicyclic compounds their preparation and pharmaceutical compositions comprising them
DE69435091D1 (de) Nigella sativa als medizinische behandlung
GB1418208A (en) Pharmaceutical compositions
ES433018A1 (es) Un procedimiento de preparacion de un nuevo derivado de oxazol.
FR2385730A1 (fr) Medicament a base d'extrait de physarum
NZ235316A (en) Vaccine containing capsular polysaccharide conjugated to recombinant c protein of a group b streptococcus, production and use against b streptococcus infection
ES412098A1 (es) Procedimiento para la produccion de inhibidores de sacara- sa.
FR2361879A2 (fr) Nouvelles 4,5,6,7- tetrahydro-7-oxo (ou hydroxy)benzo (b)thienyl-4-amines utiles notamment comme agents de croissance pour animaux et leur procede de preparation
ES434431A1 (es) Procedimiento para preparar derivados del xanteno.
GB1341794A (en) Medicament for the treatment of hepatic disorders
ES8800981A1 (es) Un procedimiento para tratar celulas efectoras que tienen receptores de superficie para la region fc de un anticuerpo
FR2419928A1 (fr) Nouveaux derives de la n-phenylalanine, leur preparation et leur application comme medicaments
FR2409996A1 (fr) 15-epi-prostacycline et analogues, utiles notamment comme agents antithrombotiques et thrombolytiques et leur procede de preparation
ES269442A1 (es) Procedimiento de preparaciën de orotato de lisina
DE3373099D1 (en) Extract of plants of the family of hypoxidaceae for treatment of cancer
FR2445339A1 (fr) Nouvelle substance antibiotique et sa preparation
FR2290203B1 (fr)
ZA872276B (en) Pharmaceutical compositions containing 5-phenyl-1,3-dioxoalkenyl compounds
FR2381786A1 (fr) Nouveaux aryl-hexafuranosides, leur preparation et leur application en tant que medicaments
FR2385714A1 (fr) Nouvel antibiotique denomme c-15003, son procede de preparation et son application comme medicament
DE3363445D1 (en) Polysaccharide substance, process for the production of same, pharmaceutical compositions containing the same and their use as medicaments
DE3363975D1 (en) Polysaccharide substance, process for the production of same, pharmaceutical compositions containing the same and their use as medicaments
FR2453153A1 (fr) Nouveau derive de dehydroproline, sa preparation et son application comme medicament

Legal Events

Date Code Title Description
ST Notification of lapse